Active ingredientIbudilastCat. No. P-I006-001CAS 50847-11-5Family · Pharmaceutical analytical standards
Ibudilast
A phosphodiesterase inhibitor, mainly of PDE4, approved in Japan in 1989 for bronchial asthma and cerebrovascular disorders, such as dizziness after a stroke; it is also being studied for multiple sclerosis and addiction. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It crosses the blood-brain barrier and calms the glial cells of the nervous system, an action that has also prompted research into neuropathic pain.
Go to the active ingredient →Active ingredientIbudilastCat. No. P-I006-001CAS 50847-11-5
Isotopically labelledIbudilast Impurity 1-d7Cat. No. P-I006-002
Isotopically labelledIbudilast-d7Cat. No. P-I006-003CAS 2713301-45-0
Impurity6,7-Dihydrodiol-ibudilastCat. No. P-I006-004CAS 101162-42-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.